Received Jun 22, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV4 | HPV (GARDASIL) | MERCK & CO. INC. | UNK | — | — |
health problems; This Spontaneous report was received from Patient and referred to a/an ( Race Unknown ) ( Ethnicity Unknown) Female patient of unknown age. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medications were not reported. On an unknown date, patient started therapy with quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine suspension for injectionUnknown Batch/Lot Number. The patient started therapy with quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine suspension for injection for the treatment of prophylaxis, On an unknown date, the patient experienced health problems (General physical health deterioration). The Outcome of General physical health deterioration was not provided. The action taken with quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine suspension for injection regarding General physical health deterioration was Not applicable with Not Applicable dechallenge and rechallenge results. The Patient considered the causality for the event General physical health deterioration to quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine suspension for injection was not reported, The Patient considered the event General physical health deterioration to be non-serious